What is the recommended dose of Teicoplanin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Teicoplanin Dosing Recommendations

For standard infections, administer a loading dose of 6 mg/kg IV every 12 hours for three doses, followed by 6 mg/kg IV once daily; for severe infections (endocarditis, septic arthritis, osteomyelitis), use 12 mg/kg IV every 12 hours for three doses, followed by 12 mg/kg IV once daily, with dosing intervals extended based on renal function. 1, 2

Loading Dose Strategy

The loading dose is critical and must be given at full dose regardless of renal function, as it depends on volume of distribution rather than clearance. 1, 2

  • Standard infections: 6 mg/kg IV every 12 hours for three doses 1, 2
  • Severe infections (S. aureus endocarditis, septic arthritis, osteomyelitis, bacteremia): 12 mg/kg IV every 12 hours for three doses 1, 2, 3
  • In critically ill patients with expanded extracellular volume from fluid resuscitation, aggressive loading is essential to rapidly achieve therapeutic levels 1
  • Failure to provide adequate loading doses leads to subtherapeutic levels regardless of renal function 1

Maintenance Dosing Based on Renal Function

After completing the loading regimen, adjust maintenance dosing according to GFR:

  • GFR >50 mL/min: 6-12 mg/kg every 24 hours 1, 2
  • GFR 10-50 mL/min: 6-12 mg/kg every 48 hours 1, 2
  • GFR <10 mL/min: 6-12 mg/kg every 72 hours 1, 2

The dose per kilogram remains the same; only the interval changes with renal impairment. 1

Infection-Specific Dosing

Severe Infections Requiring Higher Doses (12 mg/kg)

  • Endocarditis: 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily for 4-6 weeks 2, 3
  • Septic arthritis: 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily for 3-4 weeks 2, 3
  • Osteomyelitis: 12 mg/kg every 12 hours for three doses, then 12 mg/kg once daily for >6 weeks 2, 3
  • Complicated bacteremia: 12 mg/kg every 12 hours for three to six doses, then 12 mg/kg once daily for 4-6 weeks 2

Standard Infections (6 mg/kg)

  • Uncomplicated bacteremia: 6 mg/kg every 12 hours for three doses, then 6 mg/kg once daily for 2 weeks 2
  • Complicated skin and soft tissue infections: 6 mg/kg every 12 hours for three doses, then 6 mg/kg once daily for 7-14 days 2

Special Populations

Hemodialysis Patients

  • Loading dose: 12 mg/kg, followed by 6 mg/kg on days 2 and 3 1, 2
  • Maintenance: 6 mg/kg once weekly 1, 2

CAPD Peritonitis

  • IV dosing: Follow GFR <10 mL/min recommendations (every 72 hours) 1, 2
  • Intraperitoneal dosing:
    • Week 1: 20 mg/L in each bag 1, 2
    • Week 2: 20 mg/kg every other bag 1, 2
    • Week 3: 20 mg/kg in night bag only 1, 2

Continuous Renal Replacement Therapy (CVVH/CAVH)

  • Follow dosing recommendations for GFR 10-50 mL/min (every 48 hours) 1, 2

Pediatric Patients

  • Loading dose: 10 mg/kg IV every 12 hours for three doses 4
  • Maintenance dose: 6-10 mg/kg IV every 24 hours (adjust intervals for renal impairment as in adults) 4
  • For severe infections, consider 12 mg/kg loading doses and 10-12 mg/kg maintenance 4

Therapeutic Drug Monitoring

Routine monitoring is not required for most patients, but is mandatory in specific high-risk situations: 1, 2

  • S. aureus endocarditis or septic arthritis 1, 2
  • Major burns 1, 2
  • Intravenous drug users 1, 2
  • Rapidly changing renal function 1, 2
  • Immunocompromised patients 1, 2
  • Pediatric patients (due to highly variable pharmacokinetics) 4

Target Trough Concentrations

  • Standard infections: ≥10 mg/L 1, 2
  • Severe infections (endocarditis, septic arthritis, bacteremia): ≥20 mg/L 1, 2, 3
  • Therapeutic window: 15-30 mg/L for most infections 1
  • Potentially toxic levels: >60 mg/L 1, 5

Practical Considerations for Optimal Dosing

In stable adult patients with normal renal function, a 600 mg twice daily loading regimen (two doses) followed by 600 mg daily maintenance achieves therapeutic levels more frequently (68% vs 37%) without increasing toxic levels, compared to the traditional 400 mg daily dosing. 5

Common Pitfalls to Avoid

  • Never reduce loading doses for renal impairment—this leads to delayed therapeutic levels 1
  • Do not overlook the need for higher doses (12 mg/kg) in endocarditis and septic arthritis—lower doses result in treatment failure 1, 3
  • Extend dosing intervals appropriately in renal impairment—failure to do so causes drug accumulation 1
  • Monitor high-risk patients—suboptimal outcomes occur when therapeutic drug monitoring is overlooked in severe infections 1

Safety Profile

High loading doses (12 mg/kg twice daily) have an acceptable safety profile with nephrotoxicity occurring in approximately 7.9% of patients, with no increased risk compared to standard dosing when patients are appropriately monitored. 6

References

Guideline

Teicoplanin Dosing in Patients with Impaired Renal Function

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Teicoplanin Dosing Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

A critical review of the dosage of teicoplanin in Europe and the USA.

International journal of antimicrobial agents, 1994

Guideline

Teicoplanin Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.